Insights into COVID-19 vaccines development: Translation from benchside to bedside
Over the past decades, the rapid pace of vaccine development saved 37 million lives, mostly children. The ongoing corona virus disease (COVID-19) pandemic caused the death of more than 4 million worldwide. During 2020, to encounter the pandemic, scientists developed more than 300 vaccines projects a...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Health Sciences Review |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772632022000290 |
_version_ | 1828111033258999808 |
---|---|
author | Marwa Houssein Aya El Asir Al Hossainy Jana Al soussi Jana El Batch Lana El-Samadi Sherine El Imam Rawan Fakih Hoda Dakdouk Mahmoud Khalil |
author_facet | Marwa Houssein Aya El Asir Al Hossainy Jana Al soussi Jana El Batch Lana El-Samadi Sherine El Imam Rawan Fakih Hoda Dakdouk Mahmoud Khalil |
author_sort | Marwa Houssein |
collection | DOAJ |
description | Over the past decades, the rapid pace of vaccine development saved 37 million lives, mostly children. The ongoing corona virus disease (COVID-19) pandemic caused the death of more than 4 million worldwide. During 2020, to encounter the pandemic, scientists developed more than 300 vaccines projects against SARS-CoV (severe acute respiratory syndrome coronavirus 2). In 2021, the results emerging from the clinical trials led to the approval and rollout of few vaccines in different countries. To date, at least one dose of a COVID-19 vaccine has been received by more than 3.81 billion people worldwide, equal to about 49.7 percent of the world population. This review was written to the aim of providing a snapshot of COVID-19 disease, highlighting the well-known vaccines, and, finally understanding the effect of mix and match vaccines from different types. |
first_indexed | 2024-04-11T11:28:17Z |
format | Article |
id | doaj.art-80bb1c79ada74125a449883346f38b62 |
institution | Directory Open Access Journal |
issn | 2772-6320 |
language | English |
last_indexed | 2024-04-11T11:28:17Z |
publishDate | 2022-09-01 |
publisher | Elsevier |
record_format | Article |
series | Health Sciences Review |
spelling | doaj.art-80bb1c79ada74125a449883346f38b622022-12-22T04:26:14ZengElsevierHealth Sciences Review2772-63202022-09-014100040Insights into COVID-19 vaccines development: Translation from benchside to bedsideMarwa Houssein0Aya El Asir Al Hossainy1Jana Al soussi2Jana El Batch3Lana El-Samadi4Sherine El Imam5Rawan Fakih6Hoda Dakdouk7Mahmoud Khalil8Department of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, Lebanon; Department of General Sciences and English Language, College of Applied Sciences, Al Maarefa University, Riyadh, Saudi ArabiaDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, LebanonDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, LebanonDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, LebanonDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, LebanonDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, LebanonDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, LebanonDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, LebanonDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut, Lebanon; Molecular Biology Unit, Zoology Department, Faculty of Science, Alexandria University, Alexandria, Egypt; Corresponding author. Molecular Biology Unit, Zoology Department, Faculty of Science, Alexandria University, Alexandria, Egypt. Phone: (+2) 01223256303. Orcid: https://orcid.org/0000-0001-7629-4357.Over the past decades, the rapid pace of vaccine development saved 37 million lives, mostly children. The ongoing corona virus disease (COVID-19) pandemic caused the death of more than 4 million worldwide. During 2020, to encounter the pandemic, scientists developed more than 300 vaccines projects against SARS-CoV (severe acute respiratory syndrome coronavirus 2). In 2021, the results emerging from the clinical trials led to the approval and rollout of few vaccines in different countries. To date, at least one dose of a COVID-19 vaccine has been received by more than 3.81 billion people worldwide, equal to about 49.7 percent of the world population. This review was written to the aim of providing a snapshot of COVID-19 disease, highlighting the well-known vaccines, and, finally understanding the effect of mix and match vaccines from different types.http://www.sciencedirect.com/science/article/pii/S2772632022000290Human coronaviruses familySARS-CoV-2 variantsSinopharmAstrazenecaSputnik vJohnson & Johnson |
spellingShingle | Marwa Houssein Aya El Asir Al Hossainy Jana Al soussi Jana El Batch Lana El-Samadi Sherine El Imam Rawan Fakih Hoda Dakdouk Mahmoud Khalil Insights into COVID-19 vaccines development: Translation from benchside to bedside Health Sciences Review Human coronaviruses family SARS-CoV-2 variants Sinopharm Astrazeneca Sputnik v Johnson & Johnson |
title | Insights into COVID-19 vaccines development: Translation from benchside to bedside |
title_full | Insights into COVID-19 vaccines development: Translation from benchside to bedside |
title_fullStr | Insights into COVID-19 vaccines development: Translation from benchside to bedside |
title_full_unstemmed | Insights into COVID-19 vaccines development: Translation from benchside to bedside |
title_short | Insights into COVID-19 vaccines development: Translation from benchside to bedside |
title_sort | insights into covid 19 vaccines development translation from benchside to bedside |
topic | Human coronaviruses family SARS-CoV-2 variants Sinopharm Astrazeneca Sputnik v Johnson & Johnson |
url | http://www.sciencedirect.com/science/article/pii/S2772632022000290 |
work_keys_str_mv | AT marwahoussein insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT ayaelasiralhossainy insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT janaalsoussi insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT janaelbatch insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT lanaelsamadi insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT sherineelimam insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT rawanfakih insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT hodadakdouk insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside AT mahmoudkhalil insightsintocovid19vaccinesdevelopmenttranslationfrombenchsidetobedside |